taxifolin has been researched along with Age-Related Memory Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, ZQ; Ding, CB; Liu, WC; Liu, XL; Wu, M; Yang, M; Zhao, YC; Zheng, YN; Zhu, HY | 1 |
| Fukushima, M; Harada-Shiba, M; Hattori, Y; Ihara, M; Ito, H; Kalaria, RN; Maki, T; Mizuno, K; Saito, S; Takahashi, R; Yamamoto, Y | 1 |
2 other study(ies) available for taxifolin and Age-Related Memory Disorders
| Article | Year |
|---|---|
Taxifolin retards the D-galactose-induced aging process through inhibiting Nrf2-mediated oxidative stress and regulating the gut microbiota in mice.
Topics: Aging; Animals; Galactose; Gastrointestinal Microbiome; Male; Memory Disorders; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Oxidative Stress; Quercetin | 2021 |
Taxifolin inhibits amyloid-β oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy.
Topics: Amyloid beta-Peptides; Animals; Cerebral Amyloid Angiopathy; Cerebrovascular Circulation; Disease Models, Animal; Humans; Male; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neuroprotective Agents; Nootropic Agents; Protein Aggregation, Pathological; Quercetin; Random Allocation; Receptor for Advanced Glycation End Products; Spatial Memory | 2017 |